SCHEMBL22066869

SCHEMBL22066869

CCOc1c(C(N)=O)sc(C)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TSHR P16473 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ IKBKB O14920 2/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ PARP10 Q53GL7 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ PRNP P04156 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ NCOA2 Q15596 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ BPTF Q12830 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21939102 0.85 ALDH1A1 (0.37) HTTLMNATSHRALDH1A1HSD17B10
SCHEMBL3916259 0.67 MAPT (0.47) LMNATSHRALDH1A1HSD17B10MAPK1
SCHEMBL21939097 0.64 TSHR (0.49) HTTLMNATSHRALDH1A1HSD17B10
SCHEMBL11472415 0.63 LMNA (0.45) HTTLMNATSHRALDH1A1HPGD
SCHEMBL31078405 0.61 TSHR (0.41) HTTLMNATSHRALDH1A1HSD17B10
SCHEMBL5119925 0.61 FHIT (0.72) ALDH1A1HSD17B10MAPK1HPGDALOX15
SCHEMBL29686816 0.61 TSHR (0.53) HTTLMNATSHRALDH1A1MAPK1
SCHEMBL27224479 0.61 GAA (0.46) HTTTSHRALDH1A1HSD17B10MAPK1
SCHEMBL28706339 0.61 TSHR (0.53) HTTLMNATSHRALDH1A1MAPK1
SCHEMBL24488780 0.61 ALDH1A1 (0.39) HTTLMNATSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-08-01 — — US disclosed
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-08-01 — — US disclosed
EP-3625222-B1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-07-21 — — EP disclosed
US-20200179383-A1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 HTT 4542/4885LMNA 4359/4885TSHR 494/4885
US-20200179383-A1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS PTGER1, PTGER4, PTGER2 HTT 4576/4885LMNA 4498/4885TSHR 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback